Suppr超能文献

生长激素型垂体腺瘤切除术后局灶节段性肾小球硬化症患者蛋白尿显著减少:病例报告及文献复习。

Marked reduction of proteinuria after removal of a growth hormone-producing pituitary adenoma in a patient with focal segmental glomerulosclerosis: a case report and literature review.

机构信息

School of Medicine, Tohoku University, Sendai, 980-8574, Japan.

Division of Nephrology, Endocrinology, and Vascular Medicine (Current Name is Division of Nephrology, Rheumatology and Endocrinology), Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.

出版信息

CEN Case Rep. 2023 May;12(2):164-170. doi: 10.1007/s13730-022-00739-6. Epub 2022 Oct 6.

Abstract

Focal segmental glomerulosclerosis is a rare complication of acromegaly. A 74-year-old man was found to have acromegaly features such as enlargement of the forehead, nose, and hands. Laboratory tests showed a urine protein/creatinine ratio of 3.16 g/gCr and serum creatinine of 1.34 mg/dL. The levels of growth hormone and insulin-like growth factor I were markedly elevated, and the growth hormone level was not suppressed after 75 g oral glucose loading. Magnetic resonance imaging revealed a pituitary tumor with a diameter of 1.2 cm. Renal biopsy confirmed the diagnosis of focal segmental glomerulosclerosis. Transsphenoidal resection of the pituitary tumor led to remission of acromegaly and reduction in proteinuria highlighting the causal link between growth hormone overproduction and proteinuria. Treatment of acromegaly may be effective for acromegaly-associated focal segmental glomerulosclerosis.

摘要

局灶节段性肾小球硬化症是肢端肥大症的一种罕见并发症。一位 74 岁男性被发现具有肢端肥大症的特征,如额头、鼻子和手增大。实验室检查显示尿蛋白/肌酐比值为 3.16g/gCr,血清肌酐为 1.34mg/dL。生长激素和胰岛素样生长因子 I 的水平明显升高,口服 75g 葡萄糖后生长激素水平未被抑制。磁共振成像显示垂体肿瘤直径为 1.2cm。肾活检证实为局灶节段性肾小球硬化症。经蝶窦垂体肿瘤切除术导致肢端肥大症缓解,蛋白尿减少,强调了生长激素过度产生与蛋白尿之间的因果关系。治疗肢端肥大症可能对肢端肥大症相关的局灶节段性肾小球硬化症有效。

相似文献

6
Focal segmental glomerulosclerosis in association with Cushing's disease.
Clin Nephrol. 2007 Feb;67(2):109-13. doi: 10.5414/cnp67109.
9
Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
World Neurosurg. 2021 Feb;146:e1360-e1366. doi: 10.1016/j.wneu.2020.12.013. Epub 2020 Dec 9.

本文引用的文献

1
Renal effects of growth hormone in health and in kidney disease.
Pediatr Nephrol. 2021 Aug;36(8):2511-2530. doi: 10.1007/s00467-021-05097-6. Epub 2021 Jun 18.
2
Therapeutic trials in adult FSGS: lessons learned and the road forward.
Nat Rev Nephrol. 2021 Sep;17(9):619-630. doi: 10.1038/s41581-021-00427-1. Epub 2021 May 20.
3
Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria.
Cell Death Dis. 2021 Apr 1;12(4):342. doi: 10.1038/s41419-021-03643-6.
5
Podocytopathies.
Nat Rev Dis Primers. 2020 Aug 13;6(1):68. doi: 10.1038/s41572-020-0196-7.
7
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.
J Clin Endocrinol Metab. 2020 Apr 1;105(4). doi: 10.1210/clinem/dgz096.
9
Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
J Biol Chem. 2019 Nov 1;294(44):16109-16122. doi: 10.1074/jbc.RA119.008966. Epub 2019 Sep 11.
10
Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?
Front Endocrinol (Lausanne). 2019 Mar 7;10:120. doi: 10.3389/fendo.2019.00120. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验